Evidence map›Paper›PMID 21642619›Full record

ArticleInvestigative ophthalmology & visual science2011

Homocysteine-mediated modulation of mitochondrial dynamics in retinal ganglion cells.

Preethi S Ganapathy, Richard L Perry, Amany Tawfik, Robert M Smith, Elizabeth Perry, Penny Roon, B Renee Bozard, Yonju Ha, Sylvia B Smith

Open access · bronzeAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 58 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Homocysteine and Glaucoma.International journal of molecular sciences · 2023
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Implication ofInternational journal of molecular sciences · 2021
    Article
  12. Homocysteine and Mitochondria in Cardiovascular and Cerebrovascular Systems.International journal of molecular sciences · 2020
    Review
  13. Review
  14. Article
  15. Article
  16. Faulty homocysteine recycling in diabetic retinopathy.Eye and vision (London, England) · 2020
    Article
  17. Article
  18. Uncoupling Protein 2 Increases Blood Pressure in DJ -1 Knockout Mice.Journal of the American Heart Association · 2019
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Preethi S GanapathyDepartment of Cellular Biology and Anatomy, Medical College of Georgia, Augusta, Georgia, USA.
Richard L Perry
Amany Tawfik
Robert M Smith
Elizabeth Perry
Penny Roon
B Renee Bozard
Yonju Ha
Sylvia B Smith
Ophthalmology Associates (United States) · US

Funding

Role of homocysteine in retinal diseaseR01EY012830 · NEI · MEDICAL COLLEGE OF GEORGIA (MCG) · PI SMITH, SYLVIA B. · 2000 to 2016
$4.4M
Diabetic retinopathy: sigma receptor 1 (??R1) as a novel therapeutic target.R01EY014560 · NEI · MEDICAL COLLEGE OF GEORGIA (MCG) · PI SMITH, SYLVIA B. · 2004 to 2013
$2.7M
NEI NIH HHS R01 EY 012830NEI NIH HHS R01 EY012830NEI NIH HHS R01 EY014560
6 · The paper itself

Abstract

purposeTo evaluate the effect of excess homocysteine on the regulation of retinal ganglion cell mitochondrial dynamics.

methodsMice deficient in cystathionine-β-synthase (cbs) were used as a model of hyperhomocysteinemia. Gene and protein expression analyses of Opa1 and Fis1 were performed on cbs⁺/⁻ neural retinas. Mitochondria within retinal ganglion cell axons underwent systematic ultrastructural analysis to measure area, length, width, and the distance between the mitochondria and the axon wall. Primary mouse ganglion cells were cultured, treated with homocysteine, and assessed for levels of Opa1 and Fis1 protein, the number of mitochondria per length of neurite, and levels of cleaved caspase-3.

resultsOpa1 and Fis1 protein levels in cbs⁺/⁻ neural retinas were elevated to 191.00% ± 26.40% and 226.20% ± 4.57%, respectively, compared with wild-type. Mitochondria of cbs⁺/⁻ retinas were smaller in all parameters studied, including area (0.32 ± 0.01 μm² vs. 0.42 ± 0.02 μm²), compared with wild-type. Primary ganglion cells treated with homocysteine had elevations in Opa1 and Fis1 proteins, a significantly higher number of mitochondria per length of neurite (0.1781 ± 0.017 vs. 0.1156 ± 0.012), and significantly higher levels of cleaved caspase-3 compared with control.

conclusionsThis study provides the first evidence that homocysteine-induced ganglion cell loss involves the dysregulation of mitochondrial dynamics, both in vivo and in vitro. The present data suggest increased mitochondrial fission as a novel mechanism of homocysteine toxicity to neurons. Of particular relevance are glaucoma and Alzheimer's disease, neurodegenerative diseases that are associated with hyperhomocysteinemia and, more recently, have implicated increased mitochondrial fission in their pathogeneses.

Indexed as

AnimalsAnimals, NewbornAxonsCaspase 3Cells, CulturedDisease Models, AnimalDNA PrimersElectrophoresis, Polyacrylamide GelFluorescent Antibody Technique, IndirectGTP PhosphohydrolasesHomocysteineHyperhomocysteinemiaImmunoenzyme TechniquesMiceMice, Inbred C57BLMitochondriaCasp3 protein, mouseCaspase 3DNA PrimersFIS1 protein, mouseGTP PhosphohydrolasesHomocysteineMitochondrial ProteinsOpa1 protein, mouseRNA, Messenger

Identifiers

PMID21642619
PMCPMC3176036
OpenAlexW2064020686

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.